神经科

订阅

MedSci主页 / 所有栏目 / 神经科

JAMA Neurology：阿尔茨海默病患者8种血浆淀粉样蛋白Aβ42/40检测方法的比较

2021-11-15 Naomi MedSci原创

阿尔茨海默病β-淀粉样蛋白神经变性疾病Aβ老年神经科
关注

检测阿尔茨海默病(AD)中淀粉样蛋白(Aβ)病理是生物标记物在临床治疗中实施的一个重大进步。某些基于高精度免疫沉淀-耦合质谱法的方法在检测脑Aβ病理时比大多数血浆Aβ42/40免疫分析方法表现更得更好

      检测阿尔茨海默病(AD)中淀粉样蛋白(Aβ)病理的LOOD测试将是生物标记物在临床治疗中实施的一个重大进步，并在药物试验中非常有用。血液中Aβ的可靠测量被证明是具有挑战性的，直到先进的质谱和免疫检测方法的发展。在2016年，用超灵敏的SIMOA免疫测定法评估的血浆Aβ42/40被证明能以中等准确度检测异常的脑脊液β或β正电子发射断层扫描。高精度免疫沉淀-耦合质谱法(IP-MS)测定的血浆Aβ42/40后来被报道与β-PET相关，并与高精度的脑Aβ负荷异常或将来转为β-PET阳性的高风险个体相鉴别。不同的Aβ分析和平台在整个研究中的不同表现可能部分是由于队列特征(例如，样本大小、纳入的诊断组和结果测量)和分析前样本处理的差异。为了最大限度地减少这些偏倚，近日有研究人员对瑞典BIOFINDER研究中的同一组早期AD患者进行了8种Aβ检测方法的一一比较，以评估了不同方法测定的血浆Aβ42/40与正常脑脊液Aβ42/40或Aβ-PET状态的鉴别能力。

      这项研究包括182 BIOFINDER队列中认知正常的参与者和104名轻度认知障碍的患者，他们在瑞典3家不同的医院登记，从2010年到2014年接受了β正电子发射断层扫描、脑脊液和血浆采集。

      采用华盛顿大学开发的免疫沉淀耦合质谱法(IP-MS-WASU)、Araclon公司开发的无抗体液相色谱质谱(LC-MS-ARC)和罗氏诊断公司(IA-ELC)、欧洲免疫学公司(IA-EI)、阿姆斯特丹大学医学中心、ADX神经科学公司和Quanterix公司的免疫分析法(IA-N4PE)测定血浆Aβ42/40。用岛津的IP-MS法(IP-MS-SHIM)和哥德堡大学的IP-MS-UGOT法(IP-MS-UGOT)和Quanterix公司的免疫测定法(IA-Quan)分别测定了2 0 0名受试者的血浆Aβ42/40。

      为了验证，来自阿尔茨海默病神经成像计划的12名参与者(51名认知正常，51名轻度认知障碍，20名AD痴呆)接受了Aβ-PET和血浆Aβ评估，使用IP-MS-WASU，IP-MS-SHIM，IP-MS-UGOT，IA-ELC，IA-N4PE和IA-Quan分析。

      8种不同方法定量检测血浆A-β42/40对异常脑脊液A-β42/40和A-β-PET42/40状态的判别准确性

  • 共有408名参与者参与了这项研究。
  • 在BioFINDER队列中，平均年龄(SD)为71.6(5.6)岁，其中49.3%为女性。
  • 血浆IP-MS-WASU Aβ42/40与LC-MS-Arc Aβ42/40、IA-EI Aβ42/40和IA-N4PE Aβ42/40的准确性(受试者工作特征曲线下面积分别为0.86和0.81~0.90)相比，差异有统计学意义(P<0.05)。
  • 血浆IP-MS-WASU Aβ42/40显著优于IP-MS-UGOT Aβ42/40和IA-QUAβ42/40(AUC0.84vs0.68和0.64；P<0.001)，而IP-MS-WASU Aβ42/40和IP-MS-Shim Aβ42/40的AUC无明显差异(0.87vs0.83；P=0.16)。
  • 当使用Aβ-PET作为结果时，结果是相似的。
  • 血浆IPMS-WASU Aβ42/40和IPMS-Shim Aβ42/40与脑脊液Aβ42/40的相关系数最高(r=0.56~0.65)。
  • BioFINDER的结果在阿尔茨海默病神经成像倡议队列(平均[SD]年龄，72.4[5.4]岁；43.4%的女性)中得到了复制，其中IP-MS-WASU检测的表现明显优于IP-MS-UGOT、IA-ELC、IA-N4PE和IA-Quan检测，但IP-MS-Shim检测没有。

两个独立队列的结果表明，某些基于MS的方法在检测脑Aβ病理时比大多数血浆Aβ42/40免疫分析方法表现得更好。

文献来源：https://jamanetwork-com.washington.80599.net/journals/jamaneurology/fullarticle/2784411

评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-09-26 feifers

    #Aβ42#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-02-01 yinhl1978

    #Neurol#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-05-18 zhaojie88

    #阿尔茨#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-02-19 12498da4m32(暂无昵称)

    #阿尔茨海#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 ms7405317358118777

    #淀粉样蛋白#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 gracezdd

    #检测方法#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 yhj-time

    #阿尔茨海默#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2027895, encodeId=29dd202e89574, content=<a href='/topic/show?id=7fe430949f' target=_blank style='color:#2F92EE;'>#Aβ42#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3094, encryptionId=7fe430949f, topicName=Aβ42)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f1d390, createdName=feifers, createdTime=Mon Sep 26 09:28:42 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001616, encodeId=5c4120016169c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 01 05:28:42 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817135, encodeId=4ccd181e1351e, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed May 18 02:28:42 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818158, encodeId=f85a18181584e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Sat Feb 19 07:28:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442897, encodeId=c52a144289ea2, content=<a href='/topic/show?id=e112659308a' target=_blank style='color:#2F92EE;'>#淀粉样蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65930, encryptionId=e112659308a, topicName=淀粉样蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1774999170, createdName=ms7405317358118777, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1457124, encodeId=3adf145e124ca, content=<a href='/topic/show?id=b7e86254347' target=_blank style='color:#2F92EE;'>#检测方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62543, encryptionId=b7e86254347, topicName=检测方法)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe35841975, createdName=gracezdd, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470512, encodeId=e93414e05127b, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605286, encodeId=6cb816052860b, content=<a href='/topic/show?id=b820309108' target=_blank style='color:#2F92EE;'>#Aβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3091, encryptionId=b820309108, topicName=Aβ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee1c19366172, createdName=膀胱癌, createdTime=Tue Nov 16 13:28:42 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 膀胱癌

    #Aβ#

    0

相关资讯

老年痴呆被他玩明白了！剑桥大学破天荒使用人脑样本，首次发现有毒蛋白复制方式！

美国拉什大学医学中心的研究人员使用降脂药吉非贝齐和维生素A衍生物视黄酸进行联合治疗。他们发现，吉非贝齐和视黄酸联用可能改变星形胶质细胞的作用，让它们成为帮助清除β淀粉样蛋白的工具。

Neurology：淀粉样蛋白PET可预测阿尔茨海默病症状发作

散发性AD的发病年龄与达到淀粉样蛋白积累临界点的年龄密切相关。

Alz Res Therapy：脑脊液tau蛋白，助力认知功能分组

脑脊液（CSF）中的高t-tau水平被认为反映了神经元的变性或损伤，在各种涉及神经元死亡的情况下，如急性中风后，CSF中可以发现高t-tau水平。越来越高的tau亚组的特点是MMSE下降更快，发展为A

JAMA Neurology：哌醋甲酯对阿尔茨海默病患者情感淡漠的影响--ADMET-2随机临床试验

淡漠是阿尔茨海默病(AD)患者最常见的神经精神症状之一。研究发现哌醋甲酯是一种安全有效的药物，可用于治疗阿尔茨海默病的冷漠。

JAMA Neurology：左乙拉西坦对伴有与不伴有癫痫样活动的阿尔茨海默病患者认知功能的影响

在这项随机临床试验中，左乙拉西坦的耐受性很好，尽管它没有改善主要结果，但在预先指定的分析中，左乙拉西坦改善了阿尔茨海默病(AD)和癫痫样活动患者的空间记忆和执行功能任务的表现。

Alz Res Therapy：胆碱酯酶抑制剂使用，或和认知功能变化无关

在有或没有淀粉样物质负担的患者中，使用或不使用CEI与1年的随访中的认知变化无关

拓展阅读

华人学者最新Cell：治疗阿尔茨海默病，抗癌药显奇效！两款“老药”联合新用，有望恢复记忆力，逆转疾病多细胞病变

研究提出 “细胞类型导向的网络校正疗法”，用抗癌药来曲唑与伊立替康联合治疗阿尔茨海默病，在动物模型中逆转记忆损伤，多维度缓解病理。

JAMA子刊：乳腺癌患者放射治疗与降低阿尔茨海默病风险相关，而化疗及内分泌治疗则无显著影响

本研究评估了乳腺癌幸存者与AD发病风险的关系及其与不同治疗方式的潜在联系。

【骨麻征途】髋部骨折住院治疗后社区居住的阿尔茨海默病患者与非阿尔茨海默病患者的阿片类药物使用情况

本研究旨在调查因髋部骨折住院治疗后出院的社区居住AD 患者与非 AD 患者在出院后 6 个月内阿片类药物的使用率。

阿尔茨海默病(AD)：居家日常生活照护手册

阿尔茨海默病患者照护需注重日常生活协助、饮食调控、安全环境创设及照护者关怀，以延缓病情、提升生活质量。

震撼突破！暨南大学联合香港大学发布：枸杞提取物逆转阿尔茨海默病，改善视觉功能

研究发现高剂量枸杞水提物（LBE）可改善 AD 转基因小鼠的脑功能与视觉功能，减少 Aβ 和 Tau 沉积，机制与激活 WNT 通路相关。

研究发现：每天多坐一小时，大脑这里会加快萎缩，引发多种疾病！

研究表明久坐不仅增加了糖尿病、心血管疾病和癌症等慢性病的风险，更是影响大脑健康、加速认知衰退和阿尔茨海默病（AD）发生的重要隐患。

胰岛素抵抗，阿尔茨海默病的危险因素:病理机制和预防治疗方法的新建议

暂未更新 · 2024-08-19

阿尔茨海默病药物临床试验技术指导原则（试行）

国家药品监督管理局药品审评中心（CDE） · 2025-05-19

阿尔茨海默病多元康复干预中国专家共识（2025）

暂未更新 · 2025-05-15

淋巴外科手术治疗阿尔茨海默病的专家共识（2025版）

中国神经外科相关专家小组（统称） · 2025-04-29

2024版NIA-AA阿尔茨海默病诊断与分期标准更新解读：多模态影像的诊疗意义

暂未更新 · 2025-04-27

ApoE ε4检测在阿尔茨海默病临床实践中的规范应用专家共识

暂未更新 · 2024-08-25